Disease/Infection News

RSS

Infection control, widespread testing help reduce SARS-CoV-2 transmission in schools, study finds

Now, a team of researchers at the New York University Grossman School of Medicine explored which school policies had the most significant impact on reducing the risk of in-school SARS-CoV-2 transmission.

30 Nov 2020

Memory B cells persist in recovered COVID-19 patients

A team of scientists from the University of Washington, USA, and the Karolinska Institute, Sweden, has comprehensively studied the antibody-mediated immune responses in patients diagnosed with coronavirus disease 2019 (COVID-19).

30 Nov 2020

Wyss Institute’s eRapid technology licensed to The iQ Group Global

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University announced that its eRapid technology has been licensed to The iQ Group Global for COVID-19 diagnostic applications.

30 Nov 2020

New effort to increase COVID-19 testing in Louisiana's Black communities

Pennington Biomedical Research Center is leading a federally funded effort to increase COVID-19 testing in Louisiana's Black communities, which have been hit hard by the virus.

30 Nov 2020

SARS-CoV-2 immunity in the U.S. remains low

Seroprevalence studies indicate that less than 10% of people in the U. S. have detectable antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from July to September 2020.

30 Nov 2020

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

An experimental vaccine developed in Europe to prevent infection by Crimean-Congo hemorrhagic fever virus (CCHFV) has protected cynomolgus macaques in a new collaborative study from National Institutes of Health scientists.

30 Nov 2020

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.

30 Nov 2020

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

In a recent research letter published on the bioRxiv preprint server, scientists from Japan discovered that the mutation of spike glycoprotein in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) derived from farmed minks can also be found in the group of individuals with coronavirus disease (COVID-19) and subsequently evade detection by our immune system.

30 Nov 2020

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Rutgers is leading a clinical trial assessing the combination of nitazoxanide, ribavirin and hydroxychloroquine to treat people 21 or older who are infected with SARS-CoV-2 and are asymptomatic or mildly symptomatic.

30 Nov 2020

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Researchers in the United States have conducted a study demonstrating the potential of a novel therapeutic approach to treating coronavirus disease 2019 (COVID-19). The therapy augments the body’s T cell response to the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by providing a boost of rapidly expanded virus-specific T cells.

30 Nov 2020

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Researchers in Singapore have conducted a study showing that asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – mount an efficient, balanced and coordinated cellular immune response that protects the host without appearing to trigger any pathological processes.

30 Nov 2020

Oxford University podcast's third season to take listeners on a journey through historical pandemics

The University of Oxford's CASE Gold Award winning podcast, Futuremakers, will return for its third season at the end of October.

30 Nov 2020

HIV-related health services in Thailand during COVID-19 pandemic

Thailand's key population-led health services (KPLHS) are a hallmark of the success of the country's HIV response.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

A research team has reviewed the existing literature on compounds derived from molluscs used for treating respiratory diseases.

30 Nov 2020

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

In a large case study based in Mexico, researchers recently examined the mortality risk associated with diabetes in symptomatic COVID-19 patients.

30 Nov 2020

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants in a hypothetical COVID-19 dosing study.

30 Nov 2020

COVID-19 Peer Hub program works to tackle vaccine hesitancy amid pandemic

UniSA researchers are evaluating a new vaccination education initiative - the COVID-19 Peer Hub - to help immunization and public health professionals to tackle the emerging dangers of vaccine hesitancy amid the pandemic.

30 Nov 2020

Transmission 'hot zones' drive COVID-19 infection patterns, says study

A recent study describes two different mathematical models of high infection zones, which lead to different effects on viral transmission. This underlines the need to understand how the virus spreads within a community as well as within subgroups with different patterns of interaction.

30 Nov 2020

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

A new study published by a team of scientists in Spain indicates that neutralizing immunity can last for up to 8 months, despite a steep drop in antibody titer over this time.

30 Nov 2020

Disease/Infection News

Infection control, widespread testing help reduce SARS-CoV-2 transmission in schools, study finds

Memory B cells persist in recovered COVID-19 patients

Wyss Institute’s eRapid technology licensed to The iQ Group Global

New effort to increase COVID-19 testing in Louisiana's Black communities

SARS-CoV-2 immunity in the U.S. remains low

Experimental vaccine protects cynomolgus macaques against Crimean-Congo hemorrhagic fever virus

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

A mutant SARS-CoV-2 subspecies from minks may evade antibody detection

Rutgers leading a clinical trial assessing combination treatment for coronavirus

Virus induced lymphocytes show promise for COVID-19 and future pandemics

Highly functional immune response in asymptomatic SARS-CoV-2 infection

Oxford University podcast's third season to take listeners on a journey through historical pandemics

HIV-related health services in Thailand during COVID-19 pandemic

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

Mollusc-derived compounds potential medicines for COVID-19 and other respiratory diseases

Mexican case study finds similar mortality rates in diabetic patients with and without COVID-19

What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates?

COVID-19 Peer Hub program works to tackle vaccine hesitancy amid pandemic

Transmission 'hot zones' drive COVID-19 infection patterns, says study

Severe COVID-19 can produce high long-term neutralizing antibodies, study finds

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News